J. Van den Brande

发表

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)

S. Culine, M. Paesmans, A. Awada, 2021, BMC Cancer.

Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015.

C. Bokemeyer, E. Van Cutsem, C. Köhne, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

Clinical phase II study and pharmacological evaluation of rubitecan in non-pretreated patients with metastatic colorectal cancer-significant effect of food intake on the bioavailability of the oral camptothecin analogue.

A. Ganser, J. Wanders, H. Rosing, 2002, European journal of cancer.

Small-cell carcinoma of the penile urethra: a case report and a short review of the literature.

E. van Marck, M. Huizing, J. Van den Brande, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Methotrexate-associated liver toxicity in a patient with breast cancer: case report and literature review.

E. van Marck, D. Schrijvers, J. Van den Brande, 2002, The Netherlands journal of medicine.

Giant primary right ventricular synovial sarcoma.

J. Van den Brande, I. Rodrigus, B. Paelinck, 2014, European heart journal.

Phase II feasibility study of concurrent radiotherapy and gemcitabine in chemonaive patients with squamous cell carcinoma of the head and neck: long-term follow up data.

J. Weyler, M. Huizing, D. Schrijvers, 2007, Annals of oncology : official journal of the European Society for Medical Oncology.

Late relapse of a non-seminomatous germ cell tumour from residual mature teratoma.

E. van Marck, P. V. Van Schil, A. V. van Oosterom, 1998, Acta clinica Belgica.

Cytomegalovirus colitis after administration of docetaxel-5-fluorouracil-cisplatin chemotherapy for locally advanced hypopharyngeal cancer.

C. Colpaert, D. Schrijvers, J. Van den Brande, 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

Use of antiemetics in the prevention of chemotherapy-induced nausea and vomiting: review and focus on the Belgian situation.

M. Peeters, J. Van den Brande, A. Brouwer, 2014, Acta gastro-enterologica Belgica.

Merkel cell carcinoma and multiple basal cell carcinoma in an African albino woman with HIV infection

E. van Marck, C. Colpaert, J. Van den Brande, 2004, HIV medicine.

FIRE-3 and C80405: Is There a Best Choice for Initial Treatment of Metastatic Colorectal Cancer?

M. Peeters, J. Van den Brande, K. Papadimitriou, 2015, Current Colorectal Cancer Reports.

Trabectedin Followed by Irinotecan Can Stabilize Disease in Advanced Translocation-Positive Sarcomas with Acceptable Toxicity

U. Dirksen, S. Burdach, M. D’Incalci, 2016, Sarcoma.

Intraperitoneal treatment of peritoneo-venous shunt infection in a cancer patient.

D. Schrijvers, J. Van den Brande, J. Damen, 2000, Scandinavian journal of infectious diseases.

Docetaxel, ifosfamide and cisplatin in solid tumour treatment: a phase I study

J. Van den Brande, J. Vermorken, M. Huizing, 2010, Anti-cancer drugs.

Supravenous discoloration of the skin due to docetaxel treatment

D. Schrijvers, J. Van den Brande, J. Vermorken, 2000, The British journal of dermatology.

A phase I study of bendamustine hydrochloride administered day 1+2 every 3 weeks in patients with solid tumours

D. Schrijvers, J. Van den Brande, J. Vermorken, 2007, British Journal of Cancer.

Thoracic wall prosthesis prevents deep invasion by non-small-cell lung cancer.

P. V. Van Schil, D. Schrijvers, J. Van den Brande, 2000, American journal of clinical oncology.

A phase I study of bendamustine hydrochloride administered once every 3 weeks in patients with solid tumors

J. Van den Brande, J. Vermorken, D. Schrijvers, 2007, Anti-cancer drugs.

Endosonographic T-staging of esophageal carcinoma: a learning curve.

P. Fockens, G. Tytgat, J. Van den Brande, 1995, Gastrointestinal endoscopy.

Diarrhea and the rationale to use Sandostatin.

M. Peeters, J. Van den Brande, S. Francque, 2010, Acta gastro-enterologica Belgica.

Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck.

J. Van den Brande, J. Vermorken, M. Huizing, 2009, Anticancer research.

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer

J. Wanders, P. Fumoleau, J. Schellens, 2003, British Journal of Cancer.

Weekly Docetaxel in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

J. Van den Brande, P. Vroman, J. Vermorken, 2011, American journal of clinical oncology.